A new report from CDC indicates that millions of U.S. adults are not taking their medications as prescribed due to costs.

To better identify people with long COVID, researchers have identified 12 distinguishing symptoms and have developed a symptom-based scoring system.

A new study published in NEJM adds to the growing body of research on the effectiveness of ketamine for treatment-resistant depression (TRD). Results from the ELEKT-D randomized trial found that when it came to improving treatment-resistant major depression in outpatients without psychotic features, ketamine worked just as well as electroconvulsive therapy (ECT).

A new report from IQVIA Institute for Human Data Science estimates that of 7,310 prescription drugs legally dispensed to U.S. patients between January 2017 to December 2022, roughly 70% (5,085) were being actively marketed and sold by illegal online pharmacies.

A new survey from Wolters Kluwer Health reflects increasing trust in providers in non-traditional primary care settings.